Sign In
Buy FBIO
$2.61
-0.0400 (-1.51%)
At Close: Jun 03, 2026
Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
08:30am, Wednesday, 07'th Apr 2021
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or mon
Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank
07:00am, Monday, 05'th Apr 2021
SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), tod
The first and only prescription cloth towelette approved to treat primary axillary hyperhidrosis in people nine-years of age and older is Journey Medical's seventh marketed dermatology product The fir
Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights
04:15pm, Wednesday, 31'st Mar 2021
Revenue from marketed dermatology products increased 28% for full-year 2020 compared to 2019
Will Fortress Biotech (FBIO) Report Negative Q4 Earnings? What You Should Know
01:38pm, Monday, 08'th Mar 2021
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FBIO Stock Price Increased 26.03%: Why It Happened
08:54am, Wednesday, 03'rd Mar 2021
The stock price of Fortress Biotech, Inc. (Nasdaq: FBIO) has increased by 26.03%. This is why it happened.
Caelum Biosciences Announces Collaborations with the Amyloidosis Advocacy Community and Support of Amyloidosis Awareness Month
08:00am, Monday, 01'st Mar 2021
BORDENTOWN, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases, today
Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
08:00am, Friday, 26'th Feb 2021
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on acquiring, developing and commercializing or mon
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
08:00am, Monday, 22'nd Feb 2021
Catherine Bowes Rickman, Ph.D., FARVO, a leading age-related macular degeneration researcher, appointed to Scientific Advisory Board
LOS ANGELES--(BUSINESS WIRE)---- $FBIO #FBIO--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Fortress Biotech, Inc.
New York, New York--(Newsfile Corp. - January 25, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between Decem
NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and O
LOS ANGELES--(BUSINESS WIRE)---- $FBIO #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
New York, New York--(Newsfile Corp. - January 20, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the "Company") (NASDAQ: FBIO)
New York, New York--(Newsfile Corp. - January 18, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between Decem
